EFFICACY AND SAFETY OF TOLVAPTAN IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE (submitted in 2019)
4CPS-016
INAPPROPRIATE USE OF HUMAN ALBUMIN IN A TEACHING HOSPITAL (submitted in 2019)
4CPS-015
SITUATIONAL ANALYSIS OF POSTOPERATIVE IRON SUPPLEMENTATION PRESCRIPTIONS IN A PLASTIC SURGERY DEPARTMENT (submitted in 2019)
4CPS-014
CLINICAL AND ASSISTED IMPACT OF ISCHAEMICAL ICTUS IN PATIENTS TREATED WITH ORAL ANTICOAGULANTS (submitted in 2019)
4CPS-013
EFFECT OF 2MG INTRAVENOUS PHYTONADIONE TREATMENT ON INTERNATIONAL NORMALISED RATIO IN THE HOSPITALISED ADULT (submitted in 2019)
4CPS-012
AUDIT OF ORAL ANTICOAGULANT PRESCRIBING; WHAT HAS CHANGED IN 4 YEARS? (submitted in 2019)
4CPS-011
PRESCRIPTION ANALYSIS OF DIRECT ACTING ORAL ANTICOAGULANTS (submitted in 2019)
4CPS-010
SAFETY AND EFFICACY OF LOW MOLECULAR WEIGHT HEPARINS IN PATIENTS WITH PORTAL VEIN THROMBOSIS (submitted in 2019)
4CPS-009
DURATION OF DUAL ANTIPLATELET THERAPY IN CORONARY ARTERY DISEASE: IS PHARMACIST INTERVENTION NECESSARY TO IMPROVE PATIENT SAFETY? (submitted in 2019)
4CPS-008
RISK FACTORS ASSOCIATED WITH RE-ADMISSION TO THE EMERGENCY DEPARTMENT, IN PATIENTS WITH PREVIOUS GASTROINTESTINAL HAEMORRHAGE SECONDARY TO ORAL ANTICOAGULANT THERAPY (submitted in 2019)
4CPS-007
PHARMACEUTICAL CARE AS A MEANS OF PREVENTION AGAINST DRUG IATROGENESIS: CASE OF ORAL ANTICOAGULANTS (submitted in 2019)
4CPS-006
USE OF AMMONIUM TETRATHIOMOLYBDATE IN WILSON DISEASE (submitted in 2019)
4CPS-005
RISK FACTORS FOR PERSISTENCE AND TOLERANCE OF COW'S MILK ALLERGY (submitter in 2019)
4CPS-003
LIRAGLUTIDE IN CHRONIC INTESTINAL FAILURE: OVERVIEW AND CASE REPORT (submitted in 2019)
4CPS-002
ANTICHOLINERGIC BURDEN IN CONSTIPATED PATIENT ADMITTED TO AN EMERGENCY DEPARTMENT (submitted in 2019)
